|
Negative pressure wound therapy with instillation |
HAYES, Inc |
|
|
Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Negative pressure wound therapy with instillation. Lansdale: HAYES, Inc. Healthcare Technology Brief Publication. 2016 Authors' objectives Chronic wounds account for an estimated $25 billion dollars in healthcare expenditures per year. Treatment of wounds depends upon the wound type and severity; however, it typically includes debridement (surgical, mechanical, enzymatic, or biological), cleansing, and frequent changes of moist dressings.
Description of Technology: Negative pressure wound therapy (NPWT) involves the application of subatmospheric pressure to the surface of a chronic or acute wound. NPWT is thought to promote wound healing by providing a moist wound bed while removing wound fluid. NPWT with instillation (NPWTi) combines standard NPWT with timed, intermittent, delivery of a topical solution. The instillation of fluid helps to remove wound exudate, slough, and bacteria, which promotes a more rapid healing of the wound. NPWTi comprises the application of a foam dressing sealed with an adhesive film and connections for instillation and vacuum tubes. A solution is delivered to the foam dressing at preset intervals and may be allowed to dwell for a set amount of time. Subsequently, negative pressure is applied across the wound. The instillation and vacuum
cycle is repeated every 2 to 4 hours. Treatment is discontinued once the wound is ready for primary closure or coverage with a graft or flap.
Patient Population: NPWTi is indicated for patients with chronic, acute, traumatic, subacute, and dehisced wounds; partial-thickness burns; ulcers (such as diabetic, pressure, and venous insufficiency); flaps; and grafts.
Clinical Alternatives: Alternatives to NPWTi include moist dressings, hyperbaric oxygen, topical adjuvants, bioengineered skin substitutes, biologic dressings, and skin grafting or flaps. Indexing Status Subject indexing assigned by CRD MeSH Debridement; Humans; Negative-Pressure Wound Therapy; Wound Infection Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32017000076 Date abstract record published 06/01/2017 |
|
|
|